Blog Post

Arm & Hammer prepares industry for FDA guidance

In June 2021, the Food and Drug Administration (FDA) finalized guidance for industry (GFI) #263, a directive that recommends sponsors of “medically important” antimicrobial drugs that are currently approved with over the counter (OTC) marketing status voluntarily switch to Rx status. To better prepare the animal and food production industries for the shift, Arm & […]

Read More